Rethinking liver cancer diagnosis and treatment in China

Abstract

Abstract: Liver cancer has become an important public health issue in China. China has world’s largest new cases of liver cancer, accounting for 45.3% of world new cases in 2020. According to the cancer statistics released from International Agency for Research on Cancer, we updated liver cancer statistics in China and worldwide. We reported the progress of liver cancer control and prevention on risk factors. We analyzed the key research questions for liver cancer diagnosis and treatment in China. We provided strategic suggestions to optimize the roadmap of liver cancer control in the new era.

Key words: Liver cancer, Prevention, Early detection and screening, Treatment

Zeng Hongmei, Cai Jianqiang. Rethinking liver cancer diagnosis and treatment in China[J]. Electronic Journal of Liver Tumor, 2021, 8(2): 23-25.

[1]	Huang Zhangkan, Huang Xiaozhun, Xu Lin, Zhang Renjie, Che Xu, Sun Yongkun. Progress in diagnosis and treatment of combined hepatocellular cholangiocarcinoma [J]. Electronic Journal of Liver Tumor, 2021, 8(2): 43-46.
[2]	Yu Minghua, Li Wei, Ding Xiaoyan, Chen Jinglong. Predictive and prognostic factors in HCC patients treated with lenvatinib [J]. Electronic Journal of Liver Tumor, 2021, 8(2): 47-52.
[3]	Liang Yiting, Shi Susheng. Pathological diagnosis and treatment progress of hepatic epithelioid hemangioendothelioma [J]. Electronic Journal of Liver Tumor, 2021, 8(2): 53-56.
[4]	Wu Huiming, Zhao Jianjun. The whole process management strategy of irreversible electroporation in the treatment of liver cancer [J]. Electronic Journal of Liver Tumor, 2021, 8(2): 57-61.
[5]	Ge Dazhuang, Bi Xinyu, Zhao Hong, Li Zhiyu, Zhang Yefan, Luo Zhiwen, Wei Zhewen, Chen Qichen, Li Xingchen, Cai Jianqiang. Primary hepatobiliary neuroendocrine tumors: a case review and literature review [J]. Electronic Journal of Liver Tumor, 2020, 7(4): 23-28.
[6]	Li Ying, Cheng Fei, Ren Wei, He Ruixian. Effect of phased psychological intervention on the treatment of pain and anxiety after TACE in patients with primary liver cancer [J]. Electronic Journal of Liver Tumor, 2020, 7(4): 48-51.
[7]	Xu Ke, Shao Haibo. New progress of interventional therapy for liver cancer [J]. Electronic Journal of Liver Tumor, 2020, 7(3): 2-6.
[8]	Liu Chao, Zou Liang, Zheng Hui. Effects of stroke volume variation guided goal-directed fluid therapy on liver and renal function of patients after liver cancer surgery [J]. Electronic Journal of Liver Tumor, 2020, 7(3): 12-16.
[9]	Yang Min, Wang Chao, Han Binbin, Sun Rui, Yu Lei, Xu Haiyan. Prognostic value of four prognostic tools in end-stage primary liver cancer [J]. Electronic Journal of Liver Tumor, 2020, 7(3): 17-21.
[10]	Yan Xue, Han Yue. Application and progression of ablation combined with targeted therapies in the treatment of liver cancer [J]. Electronic Journal of Liver Tumor, 2020, 7(3): 36-38.
[11]	Sun Huixin, Wang Wanying, Zhang Maoxiang, Jia Haihan, Song Bingbing. Analysis of morbidity and mortality of liver cancer in Heilongjiang province, 2015 [J]. Electronic Journal of Liver Tumor, 2020, 7(2): 12-15.
[12]	Gao Fei, Liang He, Chen Qichen, Li Caiyun, Zhang Ping. Study on the need of health education guidance for liver cancer patients after discharge [J]. Electronic Journal of Liver Tumor, 2020, 7(2): 35-39.
[13]	Shao Weiwei, Sun Zhen, Song Jinghai. Current status and progress of immunotherapy for hepatocellular carcinoma [J]. Electronic Journal of Liver Tumor, 2020, 7(2): 56-60.
[14]	Li Caiyun, Liu Yan, Guo Huanfei, Bi Yafei. Study on application of pain management model based on enhanced recovery after surgery in perioperative period of liver cancer [J]. Electronic Journal of Liver Tumor, 2020, 7(2): 61-65.

Rethinking liver cancer diagnosis and treatment in China

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 14

Recommended Articles

Metrics

Comments